301 related articles for article (PubMed ID: 26511616)
1. Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
Umanah T; Ncayiyana J; Padanilam X; Nyasulu PS
BMC Infect Dis; 2015 Oct; 15():478. PubMed ID: 26511616
[TBL] [Abstract][Full Text] [Related]
2. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
Umanah TA; Ncayiyana JR; Nyasulu PS
Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
Gandhi NR; Andrews JR; Brust JC; Montreuil R; Weissman D; Heo M; Moll AP; Friedland GH; Shah NS
Int J Tuberc Lung Dis; 2012 Jan; 16(1):90-7. PubMed ID: 22236852
[TBL] [Abstract][Full Text] [Related]
5. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-EchevarrÃa A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
[TBL] [Abstract][Full Text] [Related]
6. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis.
Chem ED; Van Hout MC; Hope V
BMC Infect Dis; 2019 Aug; 19(1):723. PubMed ID: 31420021
[TBL] [Abstract][Full Text] [Related]
8. Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial.
Padayatchi N; Abdool Karim SS; Naidoo K; Grobler A; Friedland G
Int J Tuberc Lung Dis; 2014 Feb; 18(2):147-54. PubMed ID: 24429305
[TBL] [Abstract][Full Text] [Related]
9. Malnutrition associated with unfavorable outcome and death among South African MDR-TB and HIV co-infected children.
Hicks RM; Padayatchi N; Shah NS; Wolf A; Werner L; Sunkari VB; O'Donnell MR
Int J Tuberc Lung Dis; 2014 Sep; 18(9):1074-83. PubMed ID: 25189555
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho.
Satti H; McLaughlin MM; Hedt-Gauthier B; Atwood SS; Omotayo DB; Ntlamelle L; Seung KJ
PLoS One; 2012; 7(10):e46943. PubMed ID: 23115633
[TBL] [Abstract][Full Text] [Related]
11. Adherence Measured Using Electronic Dose Monitoring is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant Tuberculosis.
Bateman M; Wolf A; Chimukangara B; Brust JCM; Lessells R; Amico R; Boodhram R; Singh N; Orrell C; Friedland G; Naidoo K; Padayatchi N; O'Donnell MR
Clin Infect Dis; 2022 Oct; 75(9):1489-1496. PubMed ID: 35352097
[TBL] [Abstract][Full Text] [Related]
12. Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia.
Heysell SK; Ogarkov OB; Zhdanova S; Zorkaltseva E; Shugaeva S; Gratz J; Vitko S; Savilov ED; Koshcheyev ME; Houpt ER
Int J Tuberc Lung Dis; 2016 Feb; 20(2):187-92. PubMed ID: 26792470
[TBL] [Abstract][Full Text] [Related]
13. Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa.
Mokhele I; Jinga N; Berhanu R; Dlamini T; Long L; Evans D
BMC Pregnancy Childbirth; 2021 Jun; 21(1):453. PubMed ID: 34182944
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.
Aibana O; Bachmaha M; Krasiuk V; Rybak N; Flanigan TP; Petrenko V; Murray MB
BMC Infect Dis; 2017 Feb; 17(1):129. PubMed ID: 28173763
[TBL] [Abstract][Full Text] [Related]
15. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa.
Brust JCM; Shah NS; Mlisana K; Moodley P; Allana S; Campbell A; Johnson BA; Master I; Mthiyane T; Lachman S; Larkan LM; Ning Y; Malik A; Smith JP; Gandhi NR
Clin Infect Dis; 2018 Apr; 66(8):1246-1253. PubMed ID: 29293906
[TBL] [Abstract][Full Text] [Related]
16. High Treatment Success Rates Among HIV-Infected Multidrug-Resistant Tuberculosis Patients After Expansion of Antiretroviral Therapy in Botswana, 2006-2013.
Shin SS; Modongo C; Boyd R; Caiphus C; Kuate L; Kgwaadira B; Zetola NM
J Acquir Immune Defic Syndr; 2017 Jan; 74(1):65-71. PubMed ID: 27552155
[TBL] [Abstract][Full Text] [Related]
17. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.
Oladimeji O; Isaakidis P; Obasanya OJ; Eltayeb O; Khogali M; Van den Bergh R; Kumar AM; Hinderaker SG; Abdurrahman ST; Lawson L; Cuevas LE
PLoS One; 2014; 9(4):e94393. PubMed ID: 24722139
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence.
Satti H; McLaughlin MM; Omotayo DB; Keshavjee S; Becerra MC; Mukherjee JS; Seung KJ
PLoS One; 2012; 7(5):e37114. PubMed ID: 22629356
[TBL] [Abstract][Full Text] [Related]
19. Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success.
Daniels JF; Khogali M; Mohr E; Cox V; Moyo S; Edginton M; Hinderaker SG; Meintjes G; Hughes J; De Azevedo V; van Cutsem G; Cox HS
PLoS One; 2015; 10(11):e0142873. PubMed ID: 26555134
[TBL] [Abstract][Full Text] [Related]
20. Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa.
Brust JC; Lygizos M; Chaiyachati K; Scott M; van der Merwe TL; Moll AP; Li X; Loveday M; Bamber SA; Lalloo UG; Friedland GH; Shah NS; Gandhi NR
PLoS One; 2011 Jan; 6(1):e15841. PubMed ID: 21253585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
